|
|
Upcoming Medical Policies BlueCross BlueShield of Tennessee |
Each medical policy listed below will become effective on the date indicated, and will be included in the Medical Policy Manual for BlueCross BlueShield of Tennessee on that effective date.
Medical policies are developed using an evidence-based evaluation process. The medical evidence used in this process comes from several sources, including independent medical technology review organizations, the peer reviewed medical literature, and opinions from appropriate network specialists. All Medical Policies are reviewed by a panel of internal and external physicians before being adopted by the company.
Topics due to be included in the Medical Policy Manual on 12/12/2009
Topics due to be included in the Medical Policy Manual on 12/18/2009
Topics due to be included in the Medical Policy Manual on 1/9/2010
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Topics due to be included in the Medical Policy Manual on 12/12/2009:
Dexamethasone Intravitreal Implant
In Vivo Analysis of Colorectal Polyps
Intravenous Immune Globulin (IVIG) Therapy
Positron Emission Tomography (PET) for Oncologic Applications
Tadalafil for the Treatment of Pulmonary Hypertension
Transcatheter Hepatic Arterial Chemoembolization
Topics due to be included in the Medical Policy Manual on 12/18/2009:
Transurethral Microwave Thermotherapy
Topics due to be included in the Medical Policy Manual on 1/9/2010:
Last Review Date 11/16/2009